GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » Total Liabilities

Megasoft (NSE:MEGASOFT) Total Liabilities : ₹1,853.14 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Megasoft Total Liabilities?

Megasoft's Total Liabilities for the quarter that ended in Mar. 2024 was ₹1,853.14 Mil.

Megasoft's quarterly Total Liabilities declined from Sep. 2023 (₹1,863.30 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹1,853.14 Mil).

Megasoft's annual Total Liabilities increased from Mar. 2022 (₹1,016.46 Mil) to Mar. 2023 (₹1,834.77 Mil) and increased from Mar. 2023 (₹1,834.77 Mil) to Mar. 2024 (₹1,853.14 Mil).


Megasoft Total Liabilities Historical Data

The historical data trend for Megasoft's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft Total Liabilities Chart

Megasoft Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,908.93 1,756.78 1,016.46 1,834.77 1,853.14

Megasoft Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,834.77 - 1,863.30 - 1,853.14

Megasoft Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Megasoft's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=258.982+(1373.362+220.8
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=1,853.14

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=3658.997-1805.853
=1,853.14

Megasoft's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=258.982+(1373.362+220.8
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=1,853.14

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=3658.997-1805.853
=1,853.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Megasoft Total Liabilities Related Terms

Thank you for viewing the detailed overview of Megasoft's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Megasoft (NSE:MEGASOFT) Business Description

Traded in Other Exchanges
Address
Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081
Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft (NSE:MEGASOFT) Headlines

No Headlines